全文获取类型
收费全文 | 423篇 |
免费 | 31篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 12篇 |
妇产科学 | 28篇 |
基础医学 | 60篇 |
口腔科学 | 32篇 |
临床医学 | 46篇 |
内科学 | 70篇 |
皮肤病学 | 7篇 |
神经病学 | 32篇 |
特种医学 | 8篇 |
外科学 | 39篇 |
综合类 | 8篇 |
预防医学 | 31篇 |
眼科学 | 20篇 |
药学 | 26篇 |
中国医学 | 5篇 |
肿瘤学 | 27篇 |
出版年
2024年 | 2篇 |
2023年 | 5篇 |
2022年 | 14篇 |
2021年 | 21篇 |
2020年 | 25篇 |
2019年 | 34篇 |
2018年 | 33篇 |
2017年 | 24篇 |
2016年 | 27篇 |
2015年 | 29篇 |
2014年 | 19篇 |
2013年 | 31篇 |
2012年 | 44篇 |
2011年 | 34篇 |
2010年 | 14篇 |
2009年 | 21篇 |
2008年 | 24篇 |
2007年 | 14篇 |
2006年 | 17篇 |
2005年 | 5篇 |
2004年 | 5篇 |
2003年 | 6篇 |
2002年 | 5篇 |
2001年 | 3篇 |
1999年 | 1篇 |
排序方式: 共有457条查询结果,搜索用时 734 毫秒
81.
Kasraee B Fallahi MR Ardekani GS Ebrahimi S Doroudchi G Omrani GR Handjani F Amini M Tanideh N Haddadi M Nikbakhsh M Jahanbani S Tran C Sorg O Saurat JH 《Experimental dermatology》2006,15(7):509-514
Monobenzylether of hydroquinone (MBEH) has long been utilized for the depigmentation therapy of patients with extensive vitiligo. In this approach, the normally pigmented areas surrounding vitiligo lesions are depigmented to achieve a uniform skin tone. One of the important disadvantages of MBEH therapy, however, is the resistance of a considerable number of vitiligo patients against the depigmenting effect of this agent. We have previously proposed that the glutathione-dependent cytoprotection of melanocytes can be impaired through the inhibition of the enzyme glutathione S-transferase by retinoic acid (RA). The combination of RA with melanocytotoxic agents could thus lead to increased susceptibility of melanocytes to such compounds. In this study we have shown, for the first time, that the melanocytotoxic and depigmenting effects of MBEH are synergistically enhanced when it is combined with RA. The treatment of black guinea pig skin with RA (0.025%) alone induced no significant changes in the number of epidermal melanocytes and no skin depigmentation. On the other hand, MBEH (10%) produced mild to moderate skin depigmentation and reduced the average number of melanocytes from 76 (+/-5)/field (magnification: x 40) in control sites, to 42 (+/-6)/field in the depigmented skin. The RA (0.025%)-MBEH (10%) combination, however, produced a complete degree of depigmentation in the majority of treated sites after 10 days of application and reduced the average number of melanocytes to only 6 (+/-6)/field. RA-MBEH combination serves as a very potent skin depigmenting formula and now awaits future assessments of its potential use for the treatment of extensive vitiligo. 相似文献
82.
BackgroundFresh frozen plasma (FFP) is a major source of coagulation factor replacement therapy for patients with clotting factor deficiency. Although FFP is readily available for use in clinical practice its administration isn’t without risk. Studies on the use of FFP reveal that it is often overused or inappropriately used. We undertook an audit to assess the appropriateness of FFP transfusion in Gorgan’s hospitals.MethodsThis was a retrospective, audit done at 5 hospitals in Gorgan city regarding the use of 1592 units of FFP issued to 346 patients from March 2006 to March 2007. The appropriateness of FFP transfusion was analyzed according to British Council for Standardization in Hematology (BCSH) Guidelines 2004.ResultsIn this audit we identified a high rate of inappropriate FFP usage (53% of transfusion episodes). Most ‘Inappropriate’ FFP usage occurred when there was active bleeding, with normal (or unmeasured) coagulation tests (30% of transfusion episodes). In only 66% of FFP-transfused patients were coagulation variable measured at any point in the hospital episode.ConclusionInappropriate usage of FFP is often seen in medical facility and the right solution is needed to curb the misuse of this component. Regular utilization audit can identify correctable errors in transfusion practices. Formal education programs and existing information on FFP use should be directed to professionals ordering FFP. 相似文献
83.
84.
Sina Jannesar DDS MSc ; Hakimeh Siadat DDS MSc ; Marzieh Alikhasi DDS 《Journal of prosthodontics》2007,16(4):327-329
This article describes a technique for a two-stage selective pressure impression with a custom tray for implant-retained, tissue-supported overdentures. 相似文献
85.
Manijeh Beigi Anahita Fathi Kazerooni Mojtaba Safari Marzieh Alamolhoda Mohsen Shojaee Moghdam Shiva Moghadam Hamidreza SalighehRad Ahmad Ameri 《La Radiologia medica》2018,123(1):36-43
Purpose
To evaluate whether the pretreatment apparent diffusion coefficient (ADC) heterogeneity parameters and their alterations, after one cycle of induction chemotherapy, can be used as reliable markers of treatment response to induction chemotherapy in patients with nasopharyngeal cancer.Materials and methods
Ten patients were recruited and received induction chemotherapy (IC). Diffusion-weighted imaging was performed prior to, during, and after IC. The first-order ADC histogram parameters at the intra-treatment time-point were compared to the baseline time-point in the metastatic lymph nodes (LNs). Some ADC pretreatment parameters were combined with each other, employing discriminant analysis to achieve a feasible model to separate the complete response (CR) from the partial response (PR) groups.Results
For ten patients, significant rise in Mean and Txt1Mean (p = 0.048 and 0.015, respectively) was observed in the metastatic nodes following one cycle of IC. Txt5Energy significantly decreased (p = 0.002). Discriminant analysis on pretreatment parameters illustrated that Txt5Energypre was the best parameter to use to correctly classify CR and PR patients. This was followed by Txt9Percentile75pre, Txt1Meanpre, and Txt2Standard Deviationpre.Conclusions
Our results suggest that heterogeneity metrics extracted from ADC-maps in metastatic lymph nodes, before and after IC, can be used as supplementary IC response indicators.86.
87.
Mitra Ranjbar Fariba Keramat Mojgan Mamani Alireza Rostami Kia Fatemeh O-Sadad Khalilian Seyed Hamid Hashemi Marzieh Nojomi 《International journal of infectious diseases》2007,11(2):152-156
BACKGROUND: Combination drug therapy of brucellosis leads to recovery of symptoms, shortening of symptomatic interval, and decrease in morbidity rate, but single drug therapy is associated with more relapse episodes and a higher rate of drug resistance. Different drug combinations have been evaluated in the treatment of brucellosis. Considering the failure of treatment and relatively high rate of relapse of the disease with the World Health Organization's (WHO) recommended therapeutic regimen, we evaluated a new regimen that we assumed would increase the success of treatment and decrease the rate of relapse. In this study we compare the standard regimen of the WHO, doxycycline-rifampin (DR), to triple therapy with doxycycline-rifampin-amikacin (ADR). METHODS: Two hundred and twenty-eight consecutive patients with brucellosis, who attended Hamedan Sina Hospital between 1999 and 2001, whether seen as outpatients or as inpatients, were enrolled in the study. The participants were randomly allocated to the DR group (receiving doxycycline 100 mg twice a day and rifampin 10 mg/kg body weight/day every morning, both taken orally for eight weeks) or the ADR group (receiving doxycycline 100 mg twice a day and rifampin 10 mg/kg body weight/day every morning, both taken orally for eight weeks, plus 7.5 mg/kg amikacin intramuscularly twice a day for seven days). The patients were checked for the relief of symptoms, drug side-effects, and relapse of disease during the treatment and follow-up. RESULTS: Of the 228 patients enrolled, eight were withdrawn - four patients from the DR group and four from the ADR group. Of the remaining 220 participants (110 in the ADR group and 110 in the DR group), 107 were male (48.6%) and 113 were female (51.4%). Mean age was 35.7+/-17 years in the ADR group and 37+/-18.4 years in the DR group (p=0.5). In the DR group, 97 (88.2%) and in the ADR group, 106 (96.4%) of the patients had relief of symptoms (a significant difference by Chi-square test (p=0.04)). After completion of treatment, and at the sixth month follow-up, nine (9.3%) patients in the DR group and six (5.7%) in the ADR group experienced a relapse of the disease, with no significant difference (p=0.4). Mild side-effects were found in only 10 patients, and none required discontinuation of the therapeutic regimen. Of these patients, four were from DR group and six from ADR group; no significant difference was observed (p=0.7). CONCLUSIONS: Given the fact that the ADR regimen had a higher efficacy and more rapid action in terms of relief of symptoms compared to the DR regimen, and that no significant difference in drug side-effects and disease relapse existed in the patients of either group, adding amikacin to the DR standard treatment regimen seems beneficial. 相似文献
88.
Ehsani Fatemeh Mortezanejad Marzieh Yosephi Mohaddeseh Hafez Daniali Said Jaberzadeh Shapour 《Neurological sciences》2022,43(3):1893-1901
Neurological Sciences - One of the most common symptoms in stroke patients is spasticity. The aims were to investigate the effects of anodal trans-cranial direct current stimulation (a-tDCS) over... 相似文献
89.
Pathogenesis of polycystic ovary syndrome: what is the role of obesity? 总被引:16,自引:0,他引:16
Salehi M Bravo-Vera R Sheikh A Gouller A Poretsky L 《Metabolism: clinical and experimental》2004,53(3):358-376
Both obesity and the polycystic ovary syndrome (PCOS) are commonly seen in women of reproductive age. Fifty percent of all patients with PCOS are obese, and the presence of obesity affects the clinical manifestations of PCOS. The underlying pathogenetic mechanisms appear to involve insulin resistance and hyperinsulinemia, the magnitude of which is greater in obese than in non-obese women with PCOS. Specific effects of obesity on the manifestations of PCOS, underlying mechanisms of the interactions between obesity and PCOS, and therapeutic implications of these interactions are discussed in this article. 相似文献
90.
Gregory C Wilson Jeffrey M Sutton Milton T Smith Nathan Schmulewitz Marzieh Salehi Kyuran A Choe John E Brunner Daniel E Abbott Jeffrey J Sussman Syed A Ahmad 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(3):232-238